Skip to main content

Congress invites pharmacy benefit managers to third drug pricing hearing

By Reuters  
   March 13, 2019

The U.S. Senate Finance Committee has invited executives from five pharmacy benefit managers to testify on April 3 on the rising costs of prescription medicines, in Congress’s latest effort to question industry officials directly over an issue voters consistently cite as a top concern.

Full story


Get the latest on healthcare leadership in your inbox.